430 results on '"Narum, David L"'
Search Results
2. Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
3. Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticles
4. Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial
5. Preclinical evaluations of Pfs25-EPA and Pfs230D1-EPA in AS01 for a vaccine to reduce malaria transmission
6. Extending the range of Plasmodium falciparum transmission blocking antibodies
7. A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine
8. Author Correction: A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes
9. RTS,S/AS02A Malaria Vaccine-Induced IgG Responses Equally Recognize Native-Like Fucosylated and Nonfucosylated Plasmodium falciparum Circumsporozoite Proteins
10. Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques
11. A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes
12. Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
13. RTS, S/AS02A malaria vaccine-induced IgG responses equally recognize native-like fucosylated and non-fucosylated Plasmodium falciparum circumsporozoite proteins
14. Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults
15. Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations
16. Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins
17. Accelerated and long term stability study of Pfs25-EPA conjugates adjuvanted with Alhydrogel®
18. Immunological characterization of a VIR protein family member (VIR-14) in Plasmodium vivax-infected subjects from different epidemiological regions in Africa and South America
19. A Plasmodium falciparum RING Finger E3 Ubiquitin Ligase Modifies the Roles of PfMDR1 and PfCRT in Parasite Drug Responses
20. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria
21. Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice
22. Particle-based platforms for malaria vaccines
23. Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230
24. Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women
25. Estimation of Recent and Long-Term Malaria Transmission in a Population by Antibody Testing to Multiple Plasmodium falciparum Antigens
26. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria
27. Natural History of Malaria Infections During Early Childhood in Twins
28. Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
29. Plasmodium falciparum merozoite surface protein 1 blocks the proinflammatory protein S100P
30. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion
31. Antibodies to Plasmodium falciparum Antigens Predict a Higher Risk of Malaria But Protection From Symptoms Once Parasitemic
32. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray
33. A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection
34. Long-Lasting and Transmission-Blocking Activity of Antibodies to Plasmodium falciparum Elicited in Mice by Protein Conjugates of Pfs25
35. Natural History of Malaria Infections During Early Childhood in Twins.
36. An Invariant Protein That Colocalizes With VAR2CSA on Plasmodium falciparum-Infected Red Cells Binds to Chondroitin Sulfate A
37. Protection of Aotus Monkeys by Plasmodium falciparum EBA-175 Region II DNA Prime: Protein Boost Immunization Regimen
38. Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders
39. An Invariant Protein That Colocalizes With VAR2CSA on Plasmodium falciparum-Infected Red Cells Binds to Chondroitin Sulfate A.
40. Functional antibodies against placental malaria parasites are variant-dependent and differ by geographic region
41. Screen-less expanded bed column: new approach for the recovery and purification of a malaria transmission blocking vaccine candidate from Pichia pastoris
42. Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: A strategy for enhancing immunogenicity of malaria vaccine candidates
43. Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice
44. Antimalarial antibody repertoire defined by plasma IG proteomics and single B cell IG sequencing
45. Induction of Biologically Active Antibodies in Mice, Rabbits, and Monkeys by Plasmodium falciparum EBA-175 Region II DNA vaccine
46. Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris
47. Host cell protein quantification of an optimized purification method by mass spectrometry
48. A high affinity human monoclonal antibody against Pfs230 binds multiple parasite stages and blocks oocyst formation in mosquitoes
49. Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230
50. Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.